ç®æ¬¡ åæ¸ã ï¼ï¼ï¼ï¼ï¼£ï¼³ã«å¯¾ããä¸çã®å»å¦ä¼çã®è¦è§£ï¼ä¾ï¼åå¨ã診ææ³ï¼ ï¼ï¼ï¼ï¼ï¼£ï¼³ã®ã·ã¹ãããã£ãã¯ã»ã¬ãã¥ã¼ ï¼ï¼ï¼ï¼ï¼£ï¼³ï¼ï¼©ï¼¥ï¼©ã®ç·èª¬çãªè³æ ï¼ï¼ï¼ã¦ã£ãããã£ã¢ãåå¦ç©è³ªéæçãã®ä¸é¨è§£èª¬ 注ï¼åé¤ãã¾ãã ï¼ï¼ï¼ç±³å½ç°å¢å»å¦ã¢ã«ããã¼ãWilliam J Rea å»å¸«ãç³å·å»å¸«ãå®®ç°å»å¸« ï¼ï¼ï¼ã·ãã¯ãã¦ã¹çå群 ï¼ï¼ï¼é»ç£æ³¢éæç ä½è« âªä½è«ï¼â«ããã¼ã¿ã«ããã£ãã¼ããã«å¯¾ããæ¹å¤ã«ã¤ãã¦ããã®ä» âªä½è«ï¼â«å¤ç¨®é¡ã®åå¦ç©è³ªã«å¯¾ããæåæ§ã®å人差ã«ã¤ã㦠âªä½è«ï¼â«å¤ç¨®åå¦ç©è³ªéæç¶æ ï¼Multiple Chemical Sensitivityï¼MCSï¼ã«ããã¦ãç¥çµççå¦ã®å¯¾è±¡ã§ãããå¿æå¤åï¼Heart Rate Variabilityï¼HRVï¼ã«ã¤ãã¦ãç 究ããçµæã示ãè«æï¼å ¨æï¼ã®ãç´¹ä»ããã®ä» âªä½è«ï¼â«ååå«ç ã¨èºããã¨ã®é¢é£ã¨ã®çºè¡¨ã«ã¤ã㦠âªä½è«ï¼â«æ¿
å ¨å¡ã¨ã¯è¨ãã¾ããããæ®ã©ã®ï¼ï¼£ï¼³ã¨è¨ãããæ£è ããã第ä¸ã«æããã¨ã¯ï¼çç¶ãç¡ããªããã¨ï¼æãã¯è»½æ¸ã ã£ãã¯ãããããå°é£ãªãã°ï¼ç¨®ã ã®æ¯æ´ãå¿ è¦ã§ããçµæ¸çæ¯æ´ã§ã¯ï¼å´ç½èªå®ï¼é害年éæ¯çµ¦ãªã©ãããã¾ãã ããï¼çç¶ãç¡ããªããã¨ãæå¾ åºæ¥ããªãï¼å¹æã確èªããã¦ããªãæ°éçæ³ä¾ãã°ãæ°åããªã©ã試ããã¨ãç¡ç¢ã«ã¯å¦å®ã§ããªãã¨ããæãã¾ãããã¡ããï¼å®å ¨æ§ã®ç¢ºèªã¯å¿ é ã§ãã®ã§ä¿¡é ¼ã§ãã主治å»ãªã©ã¨ç¸è«ãã¦ä¸ã®è©±ã§ãã*1 è¨åºç°å¢å»ã¯æ£è¦ã®å»å¸«ã§ãããMCSæ£è ããã«ã¨ã£ã¦ã¯ä¿¡é ¼ãã主治å»ã§ãããããããæ²»çå¹æããã£ãã®ãªããçµæ§ãªãã¨ã§ãããã®æ²»çãä»ã®æ£è ããã§ãå¹æãæå¾ ã§ãããã®ãªã®ãçåãããã¾ããããã®æ£è ããã«éãå©çããã£ãã®ã¯äºå®ã§ããããï¼ãã ãä»ã®æ²»çã§ã¯ãã£ã¨å¹æããã£ããããããªãã¨ãããæ©ä¼æ失ã§ããå¯è½æ§ã¯æ®ããï¼ ã¨ããããã«æ¹çã«ã¯çä¿æ¡ä»¶ã¯ã¤ãã¾
åé ã«ã®ã¹ããããããã¯åå¦ç©è³ªã«é¢ããã¢ã¬ã«ã®ã¼ãç²èé害ãªã©ã®èå¨é害ãå¦å®ãã¦ããã®ã§ã¯ãªããåå¦ç©è³ªéæçï¼ï¼ï¼£ï¼©ï¼ãªãç¹å®ã®ç¾æ£æ¦å¿µã«é¢ãã¦ããããçåãæãã¦ãããããã¦ãèå¾ã«åãå·»ããã®ã«å¯¾ãã¦ç念ããã£ã¦ããã®ã§ããã ãåå¦ç©è³ªéæçãã«ç¡ç解ãçå¾ãå å¤å·å¸ãæ訴ï¼ç¥æ¸æ°èã 2007/10/03ï¼ ä¸å¹´åã¾ã§å å¤å·å¸ç«ä¸å¦æ ¡ã«éå¦ãã¦ããç·æ§ï¼ï¼ï¼ï¼ï¼é岡çä¼è±å¸ï¼ããèªèº«ã®ãåå¦ç©è³ªéæçãã¸ã®é æ ®ãæ±ããã®ã«ãå¦æ ¡å´ã®ç¡ç解ãå¨å²ã®ãããã§çç¶ãæªåããã¨ãã¦ãä¸æ¥ã¾ã§ã«ãåå¸ãç¸æã«æ²»çè²»ãæ °è¬æãªã©ç´ä¹ååç¾ä¸åã®æå®³è³ åãæ±ãã訴ããç¥æ¸å°è£å§«è·¯æ¯é¨ã«èµ·ãããã ï¼ç¥ï¼ ããã«å¯¾ããå å¤å·å¸æå§ã¯ããããã¯å 害è ãç¹å®ã§ããªãã£ãããã¯ã©ã¹å ¨ä½ãæå°ãåçºã¯ãªãã£ããæç§æ¸ã®ã¤ã³ã¯ãé¿ããããææ¥ã®ï¼¤ï¼¶ï¼¤ãä½ã£ã¦å±ãããªã©ãé æ ®ã¯ãã¦ããæ訴ã¯æ®å¿µãã¨ãã¦
MCSã¯ä½ãã®åå¦ç©è³ªã«å¤§éã«æé²ãããããå¾®éã®ç¹°ãè¿ãæé²ã«ãã£ã¦çºçãããã¨ãããããã®å¾ãå¾®éã»ï¼åå¦çã«å¿ ãããé¢é£ã®ãªãï¼å¤ç¨®é¡ã®åå¦ç©è³ªã«ããæ´é²ã«ãã£ã¦å¥åº·é害ãå¼ãèµ·ããããã¨ããããçç¶ã¯é常ã«å¤å²ã«ããã£ã¦å人差ãããã¨ãããã®ã§ãhttp://www.cssc.jp/cs.html#gãåç §ãã¦ä¸ããã MCSãåå¦ç©è³ªã®æã¤æ¯æ§ã«ããå¼ãèµ·ããããã¨ãã説å¾åã®ãã証æ ã¯ãªãã 詳細ã¯ä»¥ä¸åç §ã http://en.wikipedia.org/wiki/Multiple_chemical_sensitivity http://members.jcom.home.ne.jp/natrom/CS.html http://www.cssc.jp/ ããã¤ãã®ã¬ãã¥ã¼ãç°¡åã«ç´¹ä»ãã¾ããã Das-Munshi J, Rubin GJ, Wessely S. Multip
Tweets by @kumicit â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ããã¼ã«ã§ããªããã¨ãåå©ã®æ±ºãæã ã£ãï¼(04/09) â 人çã«æå³ãä¸ããUFO(03/14) â UFOçµ±è¨(03/14) â 2011å¹´9æ20æ¥(01/30) â 180å¹´ãããæ´å²ããããããªé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ã(08/06) â 143å¹´ã®æ´å²ãèªãé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ãUpdate 2016/08/05(08/05) â ã¡ã¢ã人種åè¦ã¨çºç ²å¤æã(07/24) â ãã¼ãã¬ã¡ãã£ã¯è¦éãããã¦ããä¸ççå¥åº·è¢«å®³(05/30) â ã¡ã¢ãã¡ã¹ã¡ãªãºã ã§æ»äººãèçããã¨æ¸ãã¦ãHahnemannã(05/08) â ã¡ã¢ããã¡ãªãã·ã¼ã¨ãã¥ããã¹ã®é¢é£èª¿æ»ä¸...ã(05/05) â ã¡ã¢ãå±æ©çç¶æ³åã§ã®éé£ã®æ¿æ²»åå¦ã(04/24) â ã¡ã¢ãç½å®³å¾ã®äººã ã®è¡åã(04/21) â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ã
Multiple chemical sensitivity (MCS) is an unrecognized and controversial diagnosis characterized by chronic symptoms attributed to exposure to low levels of commonly used chemicals.[1][2] Symptoms are typically vague and non-specific. They may include fatigue, headaches, nausea, and dizziness. Although these symptoms can be debilitating, the cause is unknown. MCS is not recognized as an organic, c
Tweets by @kumicit â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ããã¼ã«ã§ããªããã¨ãåå©ã®æ±ºãæã ã£ãï¼(04/09) â 人çã«æå³ãä¸ããUFO(03/14) â UFOçµ±è¨(03/14) â 2011å¹´9æ20æ¥(01/30) â 180å¹´ãããæ´å²ããããããªé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ã(08/06) â 143å¹´ã®æ´å²ãèªãé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ãUpdate 2016/08/05(08/05) â ã¡ã¢ã人種åè¦ã¨çºç ²å¤æã(07/24) â ãã¼ãã¬ã¡ãã£ã¯è¦éãããã¦ããä¸ççå¥åº·è¢«å®³(05/30) â ã¡ã¢ãã¡ã¹ã¡ãªãºã ã§æ»äººãèçããã¨æ¸ãã¦ãHahnemannã(05/08) â ã¡ã¢ããã¡ãªãã·ã¼ã¨ãã¥ããã¹ã®é¢é£èª¿æ»ä¸...ã(05/05) â ã¡ã¢ãå±æ©çç¶æ³åã§ã®éé£ã®æ¿æ²»åå¦ã(04/24) â ã¡ã¢ãç½å®³å¾ã®äººã ã®è¡åã(04/21) â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ã
Tweets by @kumicit â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ããã¼ã«ã§ããªããã¨ãåå©ã®æ±ºãæã ã£ãï¼(04/09) â 人çã«æå³ãä¸ããUFO(03/14) â UFOçµ±è¨(03/14) â 2011å¹´9æ20æ¥(01/30) â 180å¹´ãããæ´å²ããããããªé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ã(08/06) â 143å¹´ã®æ´å²ãèªãé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ãUpdate 2016/08/05(08/05) â ã¡ã¢ã人種åè¦ã¨çºç ²å¤æã(07/24) â ãã¼ãã¬ã¡ãã£ã¯è¦éãããã¦ããä¸ççå¥åº·è¢«å®³(05/30) â ã¡ã¢ãã¡ã¹ã¡ãªãºã ã§æ»äººãèçããã¨æ¸ãã¦ãHahnemannã(05/08) â ã¡ã¢ããã¡ãªãã·ã¼ã¨ãã¥ããã¹ã®é¢é£èª¿æ»ä¸...ã(05/05) â ã¡ã¢ãå±æ©çç¶æ³åã§ã®éé£ã®æ¿æ²»åå¦ã(04/24) â ã¡ã¢ãç½å®³å¾ã®äººã ã®è¡åã(04/21) â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ã
Tweets by @kumicit â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ããã¼ã«ã§ããªããã¨ãåå©ã®æ±ºãæã ã£ãï¼(04/09) â 人çã«æå³ãä¸ããUFO(03/14) â UFOçµ±è¨(03/14) â 2011å¹´9æ20æ¥(01/30) â 180å¹´ãããæ´å²ããããããªé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ã(08/06) â 143å¹´ã®æ´å²ãèªãé½å¸ä¼èª¬ããã¢ã¡ã¼ãã®è¡ãUpdate 2016/08/05(08/05) â ã¡ã¢ã人種åè¦ã¨çºç ²å¤æã(07/24) â ãã¼ãã¬ã¡ãã£ã¯è¦éãããã¦ããä¸ççå¥åº·è¢«å®³(05/30) â ã¡ã¢ãã¡ã¹ã¡ãªãºã ã§æ»äººãèçããã¨æ¸ãã¦ãHahnemannã(05/08) â ã¡ã¢ããã¡ãªãã·ã¼ã¨ãã¥ããã¹ã®é¢é£èª¿æ»ä¸...ã(05/05) â ã¡ã¢ãå±æ©çç¶æ³åã§ã®éé£ã®æ¿æ²»åå¦ã(04/24) â ã¡ã¢ãç½å®³å¾ã®äººã ã®è¡åã(04/21) â æ±èãã¦ã§ã¹ãã³ã°ãã¦ã¹ãã³ã³ã
2100-01-01 å¤ç¨®é¡åå¦ç©è³ªéæçï¼ï¼ï¼£ï¼³ï¼ãªã³ã¯é ç®æ¬¡ åæ¸ã ï¼ï¼ï¼ï¼ï¼£ï¼³ï¼ï¼©ï¼¥ï¼©ï¼ä¾ï¼ç¾æ£æ¦å¿µåã¯è¨ºæå称ãåã³ã診ææ³ï¼ã«å¯¾ããä¸çã®å»å¦ä¼çã®è¦è§£ ï¼ï¼ï¼ï¼ï¼£ï¼³ã®ã·ã¹ãããã£ãã¯ã¬ãã¥ã¼ ï¼ï¼ï¼ï¼ï¼£ï¼³ï¼ï¼©ï¼¥ï¼©ã®ç·èª¬çãªè³æ ï¼ï¼ï¼Clinical Ecologyã Clinical Ecologists åã³ è¨åºç°å¢å»å¦ãè¨åºç°å¢å» ï¼ï¼ï¼ï¼ï¼Clinical Ecology åã³ Clinical Ecologists ï¼ï¼ï¼ï¼ï¼è¨åºç°å¢å» åã³ è¨åºç°å¢å»å¦ ï¼ï¼ï¼ï¼ï¼£ï¼³ï¼ï¼©ï¼¥ï¼©ã¨ç²¾ç¥å»å¦ã¨ã®é¢ä¿ ï¼ï¼ï¼ï¼ï¼£ï¼³ã®æ²»çæ³ ï¼ï¼ï¼ï¼ï¼£ï¼³ï¼ï¼©ï¼¥ï¼©ã®ç 究ååï¼å«æ²»çæ³ï¼ï¼»ãã³ãã¼ã¯ï¼½ ï¼ï¼ï¼ï¼ï¼£ï¼³ï¼ï¼©ï¼¥ï¼©ã¨ã·ãã¯ãã¦ã¹çå群 ï¼ï¼ï¼ï¼ï¼£ï¼³ã®å»åæ§ ï¼ï¼ï¼ï¼ï¼ï¼£ï¼³ã«é¢ããæåããã°ç ï¼ï¼ï¼ï¼èªç¥ãã¤ã¢ã¹ãèªç¥ã®æªã¿ãèªç¥è¡åçæ³ããã¤ã³ããã«ãã¹ã¹ãã¬ã¹ä½æ¸æ³ç ï¼ï¼ï¼ï¼
ç²¾ç¥ç§Q&A ã1362ãåå¦ç©è³ªéæçã¨è¨ºæãããæ²»çã«å°çª®ãã¦ãã¾ã Q: 40代å¾åã®ç·æ§ã§ãã30æ³ã®ã¨ãè·å ´ã®ã¹ãã¬ã¹ãããããã¯çºä½ãèµ·ããããã¤çç¶ãåºããããç²¾ç¥ç§ã«éé¢ãã¾ãããè¬ç©æ²»çã§ãã ãããï¼å¹´ã»ã©ã§å®æ²»ã¾ã§è³ããªãã¾ã§ãçç¶ã¯å®å®ãã¾ããã ãã ç æ°ã«ãªã£ã¦ä»¥éãã¹ãã¬ã¹ã«å¼±ããªããç¡ç ç¶æ ãä¸å®å®ã«ãªã£ãããããã¨ããããããï¼ãï¼ã¶æã«ä¸åº¦ã®é »åº¦ã§éé¢ããé æã¨ãã¦ããã¹ããã«ã·ãªã³ãªã©ãæç¨ãã¦ãã¾ããã 4å¹´åãçµå©ã»åå± ã»å¼è¶ããããã®ã§ãããç´å¾ãã両足ã®èä¸ãããçã¿ãæ©è¡ã«æ¯éããããããã«ãªã£ããããæ´å½¢å¤ç§ãå診ãã¾ããããç°å¸¸ãªããç¥çµç§ãè¡ç®¡ç§ããã¤ã³ã¯ãªããã¯ãå診ãããã¼ã¸ã£ã¼ãåè硬åçãè åç ãªã©ã®æ¤æ»ããã¾ããããç°å¸¸ãèªãããããã¡ãã³ãã¼ã«ãã¦ãã©ãã¢ã³ãã©ã¼ã°ããªãããªã¼ã«ãªã©ãå¦æ¹ããã¾ããã ããå¹æããªããä»éª¨ã¸ã®
ã¢ã¬ã«ã®ã¼çç¶ã®çºçã«å¿ççãªè¦å ãé¢ä¸ããããã¨ã¯åºãç¥ããã¦ãã¾ããæåãªä¾ã§ã¯ã1886å¹´ã«è³é¼»ç§å»ã®ããã±ã³ã¸ã¼ã¯ããã©ã®è±ç²ã«ã¢ã¬ã«ã®ã¼ãããã¨æãè¾¼ãã§ãã32æ³ã®å¥³æ§ã®çä¾ãå ±åãã¦ãã¾ãã ããã±ã³ã¸ã¼ã¯ãã®å¥³æ§ãçã«ãã©è±ç²ã«ã¢ã¬ã«ã®ã¼ããããã©ããã調ã¹ãããã«ã人工çã«ä½ã£ãæ¸ æ½ãªãã©ã®é è±ãç¨æãã¾ãããããã¦è¨ºå¯ã®æä¸ã«ãé è±ã§ããã¨ã¯ç¥ãããããã®é è±ã女æ§ã«è¦ããã¨ãããé¼»è ãå£è ã®çºèµ¤ãé¼»æ±ã®åæ³ãè¦ããã¾ããããã©ã®è±ç²ãªãã§ããã¢ã¬ã«ã®ã¼çç¶ãå¼ãããããã¨ãã§ããã®ã§ããããã±ã³ã¸ã¼ã¯ããã®å¥³æ§ã«ããã©ãæ¬ç©ã§ã¯ãªããã¨ãç¥ããã¾ããã彼女ã¯é©ãã¾ããããæ°æ¥ã®ãã¡ã«ãæ¬ç©ã®ãã©ãã¢ã¬ã«ã®ã¼çç¶ãªãã«å ããããã«ãªã£ãããã§ãã ãã®è©±ã¯ããã¸ã示åçãªã®ã§ãä»å¾ããã®ãã¼ã¸ã§ã¯ä½åº¦ãç»å ´ãã¾ãããã®ãã©ã¢ã¬ã«ã®ã¼ã§ããã¨æãè¾¼ãã§ãã女æ§ãä»®ã«ããºï½¥
2018å¹´05æ30æ¥ å¹³ç´ ããã¿ããªã®ç¿»è¨³ãµã¤ãããå©ç¨ããã ãèª ã«ãããã¨ããããã¾ãã ãã®åº¦ã2018å¹´05æ30æ¥ 10:00ããããµã¼ã移è¡ã«ä¼´ããµã¼ãã¹ãä¸æåæ¢ããã¦ããã ãã¾ãã â»ä½æ¥å®äºäºå®ã¯æªå®ã¨ãªãã¾ãã å®äºææãåãã次第ããµã¤ãä¸ã§é£çµ¡ããã¦ããã ãã¾ãããè¿·æããæãããç³ã訳ãããã¾ãããããã°ãããå¾ ã¡ãã ããã
åå¦ç©è³ªéæçï¼ãããã¶ã£ãã¤ãã³ããããï¼ã¾ãã¯å¤ç¨®åå¦ç©è³ªéæç¶æ ï¼è±èª: MCSï¼Multiple Chemical Sensitivityï¼ã¨ã¯ãé常ã®äººã§ããã°çç¶ãåºããªããããªå¾®éãªç°å¢ä¸ã®åå¦ç©è³ªã«åå¿ãã¦ã種ã ã®å¤å½©ãªçç¶ã訴ããç æ ã§ãèªè¦çç¶ãåºæ¬ã¨ãªãèªå¾ç¥çµç³»ã®ä¸å®æ訴ãç²¾ç¥ç¥çµçç¶ãã¯ããã¨ããå¤å½©ã§éç¹ç°çãªçç¶ã訴ãã[1][2][3][4][5][6]ãå½éåå¦ç©è³ªå®å ¨æ§è¨ç»ï¼WHO/IPCSï¼ã¯ãçç¶ã®åå ãç°å¢ä¸ã®ç¹å®ã®åå¦ç©è³ªã¨ã¯æå®ã§ãããå æé¢ä¿ã証æã§ããªããã¨ãããåå¦ç©è³ªãã¨ããè¨èã¯ä½¿ãããæ¬æ æ§ç°å¢ä¸èçï¼IEIï¼Idiopathic Environmental Intoleranceï¼ã¨ããè¨èã使ã£ã¦ãã[1][7]ã çç¶ã¯ãåæ¸ãè¸çãçºæ±ãæ¯åããç²å´ãç´ æ½®ããã¾ããªã©å¤å½©ã§ããããèå¨ã®æ©è½é害ãªã©èº«ä½å¾´åãè¦ãããªããã®ã¨
Not your computer? Use a private browsing window to sign in. Learn more about using Guest mode
SIVADããã®ããã°ã赤ã®å¥³çã¨ãè¶ããã®ã¨ã³ããªã¼ ãNATROMæ°ãåå¦ç©è³ªéæçã¯è¨åºç°å¢å»ã®ã¤ãã£ããå»åç ãã ã¨æããçã«ã¤ãã¦ã http://d.hatena.ne.jp/sivad/20130704/p1 ã«ã³ã¡ã³ããã¾ãããï¼åé¤ããã¾ããã ãé·æã³ã¡ã³ãã¯è¿·æã ããèªåã®ããã°ã§ã©ãããã¨ããããã£ã¨ããªçç±ã§ï¼å¤§å¤å¤±ç¤¼ãã¾ããã ã¨ãããã¨ã§ï¼ä»æ´ãªããï¼èªåã®ããã°ãéè¨ãããã¨ã«ãã¾ããã ã¾ãï¼SIVADããã®ã¨ããã¸ã®ã³ã¡ã³ããåæ²ãã¾ããï¼æ稿æã®èª¤åã¯è¨æ£ãã¾ããããæ¹åãâãå ±åãï¼ ã¯ããã¾ãã¦ã >ãåå¦ç©è³ªéæçãã¯åè ãç å åºæºãã«ãããã¨ããã¾ãããããããã®åå ã§ãããåå¦ç©è³ªãããã®æ©åºã«ã¤ãã¦ã¯ã¾ã ã¯ã£ããããã£ã¦ãã¾ããã ãç å åºæºãã§ãããªããï¼åå ã§ãããåå¦ç©è³ªãã«ã¤ãã¦ã¯åãã£ã¦ããªãã¨ããã®ã¯çç¾ã§ã¯ããã¾ãããããåå¦
SIVADããã¯ï¼æ並ç ãå¼ãåãã«åºãã¦ãã¾ããï¼å ¬èª¿å§ã¯æ並ç ããåå¦ç©è³ªéæçãã¨èªãã¦ãã¾ããã å ¬èª¿å§è£å®ã®è¦æ¨ã¯ä»¥ä¸ã®éãã§ãã http://www.soumu.go.jp/kouchoi/activity/suginam.html ï¼ï¼ç³è«äººï¼¡ï¼ç³è«äººã®ãã¡ã®ä¸äººï¼ã®H8å¹´4æãã8æé ã«çãã被害ã®åå ã¯ï¼æ並ä¸ç¶æããæåºãããåå¦ç©è³ªã«ããã¨èªããããã ï¼ï¼ç³è«äººï¼¡ã®ï¼¨8å¹´9æ以éã«çãã被害ã®åå ï¼åã³ç³è«äººï¼¡ä»¥å¤ã®ç³è«äººã®è¢«å®³ã®åå ã¯ï¼æ並ä¸ç¶æããæåºãããåå¦ç©è³ªã«ããã¨èªããããªãã ç³è«äººã¯ãåå¦ç©è³ªéæçãæ£è ã§ãããï¼ç³è«äººä»¥å¤ã®ä½æ°ã«ã被害ãçºçãã¦ããï¼ãããã®ä½æ°ã¨å± ä½ç¶æ³ãªã©ãåãã¨è¦ãªããç³è«äººï¼¡ã«ã¤ãã¦ï¼8æã¾ã§ã®è¢«å®³ã®åå ãæ並ä¸ç¶æã¨è£å®ãã¦ããã®ã§ããå¨è¾ºä½æ°ã®è¢«å®³ã¯ï¼¨ï¼å¹´ï¼æããï¼æã«éä¸ãã¦ããï¼ï¼æ以éã¯äººæ°ã大ããæ¸ãï¼å°ç
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}